Results 31 to 40 of about 28,908 (228)

Effect of Educational Package on Complications Associated with Plasmapheresis among Patients with Autoimmune Disorders [PDF]

Egyptian Journal of Health Care, 2020
Autoimmune disorders represent an extreme range of clinical conditions affecting different organs, with the production of autoantibodies as a main pathogenic mechanism that strongly needs treatment with plasmapheresis.
Sabah Nazeh Mohamed Elderiny, Shereen Abd El-Moneam Ahmed   +1 more
doaj   +1 more source

Plasmapheresis as a viable treatment option for scleritis

American Journal of Ophthalmology Case Reports, 2022
Purpose: We describe a case and our experience with using plasmapheresis as a treatment for scleritis. Observations: Treating relapsing autoimmune scleritis can be challenging when it inadequately responds to traditional therapy.
Janine M. Preble, Xihui Lin
doaj   +1 more source

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Correlation and mediation analysis between plasmapheresis donation behavior and bone mineral density and bone metabolism biomarkers: a cross-sectional study based on plasmapheresis donors at high risk of osteoporosis in China [PDF]

PeerJ
Background As a group of more than 3.67 million people, the bone health of Chinese plasmapheresis donors, which the main population is also a risk group of osteoporosis (OP), has raised concerns.
Wan Li, Jia Liu, Changqing Li, Hui Yang, Yating Yang, Zhiwei Li, Shouqiang Yang, Yuan He, Guanglin Xiao, Ya Wang, Yongjun Chen   +10 more
doaj   +2 more sources

A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design

Frontiers in Nephrology, 2023
BackgroundFocal segmental glomerulosclerosis (FSGS) is a common cause of end-stage kidney disease requiring kidney transplantation and can recur in the allograft in 30-80% of recipients resulting in reduced graft survival.
Michelle N. Rheault, Sandra Amaral, Margret Bock, Eileen Tsai Chambers, Blanche Chavers, Mireile El Ters, Rouba Garro, Rasheed Gbadegesin, Amit Govil, Lyndsay Harshman, Hatem Amer, David K. Hooper, David K. Hooper, Ajay K. Israni, Ajay K. Israni, Samy Riad, Junichiro Sageshima, Ron Shapiro, Michael Seifert, Jodi Smith, Randall Sung, Christie P. Thomas, Qi Wang, Priya S. Verghese   +23 more
doaj   +1 more source

Peran Plasmafaresis pada Terapi Pasien Sepsis dengan Myasthenia Gravis

JAI (Jurnal Anestesiologi Indonesia), 2013
Pendahuluan : Plasmapheresis berpotensi untuk menghilangkan mediator berbahaya atau beracun dari sirkulasi . Plasmapheresis telah menunjukkan peningkatan keluaran yang bermakna pada penyakit autoimun .
Ahmad Imron, Dita Aditianingsih, Yohanes W George   +2 more
doaj   +1 more source

To Evaluate the Effectiveness of Plasmapheresis as a Method for the Graft Disease Prevention in Patients with Keratoplasty

Oftalʹmologiâ, 2021
Purpose: to evaluate the effectiveness of plasmapheresis as a method for preventing and treating the graft rejection reaction in corneal transplantation.Patients and methods.
S. N. Sakhnov, V. V. Myasnikova, K. I. Melkonyan, S. V. Kravchenko   +3 more
doaj   +1 more source

Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)

Pulmonology, 2021
Background In December 2019, pneumonia associated with a novel coronavirus (COVID-19) was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is the most frequently observed complication in COVID-19 patients with high mortality rates ...
Seyed MohammadReza Hashemian, Navid Shafigh, Golnaz Afzal, Hamidreza Jamaati, Payam Tabarsi, Majid Marjani, Majid Malekmohammad, Seyed Mehdi Mortazavi, Batoul Khoundabi, Davood Mansouri, Afshin Moniri, Abbas Hajifathali, Elham Roshandel, Esmaeil Mortaz, Ian M Adcock   +14 more
doaj   +3 more sources

Plasmapheresis for Spur Cell Anemia in a Patient with Alcoholic Liver Cirrhosis

Case Reports in Hematology, 2018
Background. Spur cell anemia (SCA) is a cause of hemolytic anemia in patients with alcoholic liver cirrhosis. Because dyslipidemia is related to the development of spur cells, SCA was previously treated with plasmapheresis. Case Report.
Kenji Miki, Takashi Maruki, Shinsaku Imashuku   +2 more
doaj   +1 more source